BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendoza J, Abreu M. Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 2009;33:S158-73. [DOI: 10.1016/s0399-8320(09)73151-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Vaiopoulou A, Gazouli M, Theodoropoulos G, Zografos G. Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci. 2012;57:2755-2764. [PMID: 22740064 DOI: 10.1007/s10620-012-2291-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ciorba MA. Indoleamine 2,3-dioxygenase in intestinal disease. Curr Opin Gastroenterol. 2013;29:146-152. [PMID: 23283180 DOI: 10.1097/mog.0b013e32835c9cb3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
3 Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front Nutr 2022;8:818902. [DOI: 10.3389/fnut.2021.818902] [Reference Citation Analysis]
4 Oshi MA, Lee J, Naeem M, Hasan N, Kim J, Kim HJ, Lee EH, Jung Y, Yoo J. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core–Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis. Biomacromolecules 2020;21:3571-81. [DOI: 10.1021/acs.biomac.0c00589] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
5 Cioffi M, Rosa AD, Serao R, Picone I, Vietri MT. Laboratory markers in ulcerative colitis: Current insights and future advances. World J Gastrointest Pathophysiol 2015; 6(1): 13-22 [PMID: 25685607 DOI: 10.4291/wjgp.v6.i1.13] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
6 Zhang MH, Wang H, Wang HG, Wen X, Yang XZ. Effective immune-inflammation index for ulcerative colitis and activity assessments. World J Clin Cases 2021; 9(2): 334-343 [PMID: 33521101 DOI: 10.12998/wjcc.v9.i2.334] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Meng LL, Wu ZJ. Clinical utility of fecal neutrophil-derived biomarkers in evaluating activity of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2014; 22(35): 5473-5479 [DOI: 10.11569/wcjd.v22.i35.5473] [Reference Citation Analysis]
8 Rodrigues BL, Mazzaro MC, Nagasako CK, Ayrizono MLS, Fagundes JJ, Leal RF. Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World J Gastrointest Endosc 2020; 12(12): 504-520 [PMID: 33362904 DOI: 10.4253/wjge.v12.i12.504] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res 2012;11:3344-57. [PMID: 22574726 DOI: 10.1021/pr300139q] [Cited by in Crossref: 145] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
10 Karatzas PS, Mantzaris GJ, Safioleas M, Gazouli M. DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease. Medicine (Baltimore) 2014;93:e309. [PMID: 25526479 DOI: 10.1097/MD.0000000000000309] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 6.9] [Reference Citation Analysis]
11 Naeem M, Cao J, Choi M, Kim WS, Moon HR, Lee BL, Kim MS, Jung Y, Yoo JW. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles. Int J Nanomedicine 2015;10:4565-80. [PMID: 26213469 DOI: 10.2147/IJN.S87816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
12 Wang JQ, Huang Y. Serological markers of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4110-4115 [DOI: 10.11569/wcjd.v21.i36.4110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Liu L, Chen H, Brecher MB, Li Z, Wei B, Nandi B, Zhang J, Ling H, Winslow G, Braun J, Li H. Pfit is a structurally novel Crohn's disease-associated superantigen. PLoS Pathog 2013;9:e1003837. [PMID: 24385909 DOI: 10.1371/journal.ppat.1003837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Oshi MA, Lee J, Kim J, Hasan N, Im E, Jung Y, Yoo JW. pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis. Pharmaceutics 2021;13:1412. [PMID: 34575488 DOI: 10.3390/pharmaceutics13091412] [Reference Citation Analysis]
15 Xiang BJ, Jiang M, Sun MJ, Dai C. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Visc Med 2021;37:338-48. [PMID: 34722717 DOI: 10.1159/000514196] [Reference Citation Analysis]
16 Bennike TB, Carlsen TG, Ellingsen T, Bonderup OK, Glerup H, Bøgsted M, Christiansen G, Birkelund S, Stensballe A, Andersen V. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies. Inflamm Bowel Dis. 2015;21:2052-2067. [PMID: 25993694 DOI: 10.1097/mib.0000000000000460] [Cited by in Crossref: 74] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
17 Mortensen JH, Manon-Jensen T, Jensen MD, Hägglund P, Klinge LG, Kjeldsen J, Krag A, Karsdal MA, Bay-Jensen AC. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease. PLoS One 2017;12:e0185855. [PMID: 29028807 DOI: 10.1371/journal.pone.0185855] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
18 Kyriakidi KS, Tsianos VE, Karvounis E, Christodoulou DK, Katsanos KH, Tsianos EV. Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases. Ann Gastroenterol 2016;29:258-67. [PMID: 27366026 DOI: 10.20524/aog.2016.0028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
19 Duman AE, Hülagü S, Çelebi A, Korkmaz U, Musul MM, Şentürk Ö, Şirin G, Yılmaz H, Koç DÖ, Dindar G, Öztürkler M, Bozkurt N, Kır HM. Differential diagnosis of Crohn's disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae. Turk J Gastroenterol 2019;30:21-7. [PMID: 30465525 DOI: 10.5152/tjg.2018.18135] [Reference Citation Analysis]
20 Pellino G, Selvaggi F, Ghezzi G, Corona D, Riegler G, Delaini GG. A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease. Tech Coloproctol 2015;19:639-51. [PMID: 26403232 DOI: 10.1007/s10151-015-1368-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
21 Poulsen NA, Andersen V, Møller JC, Møller HS, Jessen F, Purup S, Larsen LB. Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis. BMC Gastroenterol. 2012;12:76. [PMID: 22726388 DOI: 10.1186/1471-230x-12-76] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
22 Kuna AT. Serological markers of inflammatory bowel disease. Biochem Med (Zagreb). 2013;23:28-42. [PMID: 23457764 DOI: 10.11613/BM.2013.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
23 Shentova-eneva R, Velikova T. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New? Gastroenterology Insights 2020;11:58-71. [DOI: 10.3390/gastroent11020009] [Reference Citation Analysis]
24 Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
25 Park JM, Han NY, Han YM, Chung MK, Lee HK, Ko KH, Kim EH, Hahm KB. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics? World J Gastroenterol 2014; 20(37): 13466-13476 [PMID: 25309077 DOI: 10.3748/wjg.v20.i37.13466] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Gergely M, Deepak P. Tools for the Diagnosis and Management of Crohn's Disease. Gastroenterol Clin North Am 2022;51:213-39. [PMID: 35595412 DOI: 10.1016/j.gtc.2021.12.003] [Reference Citation Analysis]
27 Naeem M, Bae J, Oshi MA, Kim MS, Moon HR, Lee BL, Im E, Jung Y, Yoo JW. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis. Int J Nanomedicine 2018;13:1225-40. [PMID: 29535519 DOI: 10.2147/IJN.S157566] [Cited by in Crossref: 41] [Cited by in F6Publishing: 11] [Article Influence: 10.3] [Reference Citation Analysis]
28 Iskandar HN, Ciorba MA. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res. 2012;159:313-325. [PMID: 22424434 DOI: 10.1016/j.trsl.2012.01.001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 11.6] [Reference Citation Analysis]
29 Hesselager MO, Codrea MC, Sun Z, Deutsch EW, Bennike TB, Stensballe A, Bundgaard L, Moritz RL, Bendixen E. The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine. Proteomics 2016;16:634-44. [PMID: 26699206 DOI: 10.1002/pmic.201500195] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
30 Bennike T, Birkelund S, Stensballe A, Andersen V. Biomarkers in inflammatory bowel diseases: Current status and proteomics identification strategies. World J Gastroenterol 2014; 20(12): 3231-3244 [PMID: 24696607 DOI: 10.3748/wjg.v20.i12.3231] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]